Your browser doesn't support javascript.
loading
Pro-phagocytic function and structural basis of GPR84 signaling.
Zhang, Xuan; Wang, Yujing; Supekar, Shreyas; Cao, Xu; Zhou, Jingkai; Dang, Jessica; Chen, Siqi; Jenkins, Laura; Marsango, Sara; Li, Xiu; Liu, Guibing; Milligan, Graeme; Feng, Mingye; Fan, Hao; Gong, Weimin; Zhang, Cheng.
Afiliação
  • Zhang X; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Wang Y; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
  • Supekar S; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Cao X; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 138671, Singapore.
  • Zhou J; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Dang J; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Chen S; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Jenkins L; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Marsango S; Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K.
  • Li X; Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K.
  • Liu G; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Milligan G; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Feng M; Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K.
  • Fan H; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Gong W; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 138671, Singapore.
  • Zhang C; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Res Sq ; 2023 Feb 15.
Article em En | MEDLINE | ID: mdl-36824923
ABSTRACT
GPR84 is a unique orphan G protein-coupled receptor (GPCR) that can be activated by endogenous medium-chain fatty acids (MCFAs). The signaling of GPR84 is largely pro-inflammatory, which can augment inflammatory response, and GPR84 also functions as a pro-phagocytic receptor to enhance the phagocytic activities of macrophages. In this study, we first showed that the activation of GPR84 by the synthetic agonist 6-OAU could synergize with the blockade of CD47 on cancer cells to induce phagocytosis of cancer cells by macrophages. Then, we determined a high-resolution structure of the GPR84-Gi signaling complex with 6-OAU. This structure revealed a completely occluded binding pocket for 6-OAU, the molecular basis of receptor activation involving non-conserved structural motifs of GPR84, and an unusual Gi-coupling interface. Together with computational docking and simulations studies, our structure also suggested the mechanism for the high selectivity of GPR84 for MCFAs and the potential routes of ligand binding and dissociation. Our results provide a framework for understanding GPR84 signaling and developing new drugs targeting GPR84.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Sq Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Sq Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China